Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA Follow-up Study.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8969737.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A child was treated from age 18 months to 8 years with oral methoxsalen and ultraviolet A radiation (PUVA) for refractory psoriasis. Two basal cell cancers developed before age 21 years, suggesting that exposure to PUVA in childhood increases the risk of basal cell cancer.
Medical subject headings
- Basal Cell Carcinoma
- Methoxsalen
- Neoplasms, Radiation-Induced
- PUVA Therapy
- Skin Neoplasms